Literature DB >> 6872871

[Erythema migrans disease. A contribution to its clinical features and relation to Lyme disease].

K Weber, A Puzik, T Becker.   

Abstract

A largely prospective study averaging 33 months was undertaken in 30 patients with and one without (chronic) erythema migrans. In one case erythema migrans disappeared spontaneously, in the 29 others it persisted up to six months, but quickly responded to antibiotic treatment. Measured from the tick bite in 9 patients or from onset of the erythema migrans, arthritis and arthralgia appeared in ten patients on average 6.5 months (0.7-36), and persisted for eight months (0.2-42). In seven of these patients sensory disturbances appeared three weeks (1-10) later and (or) signs of meningitis which lasted for four months (0.5-16), while in three patients cardiac symptoms appeared a few weeks later, persisting for 4.5 months (0.3-12). In one patient tracheolaryngitis developed two months later, persisting for three months. These manifestations occurred in seven patients despite antibiotic treatment. Extradermal manifestations in two patients were successfully treated with high parenteral penicillin doses, in one instance followed by tetracyclin. "Erythema migrans disease", differing from Lyme disease described in the U.S.A. in only a few aspects, apparently cannot be successfully treated with low oral doses of penicillin, but can in certain circumstances be favourably influenced by high parenteral doses of penicillin G.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872871     DOI: 10.1055/s-2008-1069719

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  9 in total

1.  Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers.

Authors:  L Bennet; A Halling; J Berglund
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-07       Impact factor: 3.267

2.  Lyme arthritis: clinical features, serological, and radiographic findings of cases in Germany.

Authors:  P Herzer; B Wilske; V Preac-Mursic; G Schierz; M Schattenkirchner; N Zöllner
Journal:  Klin Wochenschr       Date:  1986-03-03

3.  Lymphocytic meningoradiculitis of Bannwarth and erythema migrans disease.

Authors:  K Weber
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

4.  Serological diagnosis of erythema migrans disease and related disorders.

Authors:  B Wilske; G Schierz; V Preac-Mursic; K Weber; H W Pfister; K Einhäupl
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

5.  Reinfection in erythema migrans disease.

Authors:  K Weber; G Schierz; B Wilske; U Neubert; H E Krampitz; A G Barbour; W Burgdorfer
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

6.  Ixodes ricinus spirochete and European erythema chronicum migrans disease.

Authors:  R Ackermann; J Kabatzki; H P Boisten; A C Steere; R L Grodzicki; S Hartung; U Runne
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

7.  Discovery of the Lyme Disease Agent.

Authors:  Alan G Barbour; Jorge L Benach
Journal:  mBio       Date:  2019-09-17       Impact factor: 7.867

8.  Bannwarth's syndrome (lymphocytic meningoradiculitis) in Sweden.

Authors:  B Ryberg
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

9.  European erythema migrans disease and related disorders.

Authors:  K Weber; G Schierz; B Wilske; V Preac-Mursic
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.